175 related articles for article (PubMed ID: 32059452)
41. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
[TBL] [Abstract][Full Text] [Related]
42. Heme oxygenase-1 as a protective gene.
Bach FH
Wien Klin Wochenschr; 2002; 114 Suppl 4():1-3. PubMed ID: 15499991
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury.
Cheng Y; Rong J
Curr Pharm Des; 2017; 23(26):3884-3898. PubMed ID: 28412905
[TBL] [Abstract][Full Text] [Related]
44. Heme breakdown and ischemia/reperfusion injury in grafted liver during living donor liver transplantation.
Matsumi J; Morimatsu H; Matsusaki T; Kaku R; Shimizu H; Takahashi T; Yagi T; Matsumi M; Morita K
Int J Mol Med; 2012 Feb; 29(2):135-40. PubMed ID: 22037960
[TBL] [Abstract][Full Text] [Related]
45. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
[TBL] [Abstract][Full Text] [Related]
46. Unrelated donor bone marrow transplantation for hematological malignancies-current status.
Davies SM; Wagner JE; Weisdorf DJ; Shu XO; Blazar BR; Enright H; McGlave PB; Ramsay NK
Leuk Lymphoma; 1996 Oct; 23(3-4):221-6. PubMed ID: 9031102
[TBL] [Abstract][Full Text] [Related]
47. Heme oxygenase and the cardiovascular-renal system.
Abraham NG; Kappas A
Free Radic Biol Med; 2005 Jul; 39(1):1-25. PubMed ID: 15925276
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation.
MacMillan ML; Radloff GA; DeFor TE; Weisdorf DJ; Davies SM
Br J Haematol; 2003 May; 121(4):597-604. PubMed ID: 12752101
[TBL] [Abstract][Full Text] [Related]
49. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.
Yokoyama H; Kanda J; Fuji S; Kim SW; Fukuda T; Najima Y; Ohno H; Uchida N; Ueda Y; Eto T; Iwato K; Kobayashi H; Ozawa Y; Kondo T; Ichinohe T; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2017 Feb; 23(2):300-309. PubMed ID: 27845190
[TBL] [Abstract][Full Text] [Related]
50. The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Horio T; Mizuno S; Uchino K; Mizutani M; Hanamura I; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Takami A
Transpl Immunol; 2017 Jun; 42():34-39. PubMed ID: 28487238
[TBL] [Abstract][Full Text] [Related]
51. The Protective Role of Heme Oxygenase-1 in Atherosclerotic Diseases.
Kishimoto Y; Kondo K; Momiyama Y
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344980
[TBL] [Abstract][Full Text] [Related]
52. Heme oxygenase-1 system in organ transplantation.
Katori M; Busuttil RW; Kupiec-Weglinski JW
Transplantation; 2002 Oct; 74(7):905-12. PubMed ID: 12394829
[TBL] [Abstract][Full Text] [Related]
53. Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.
Bachanova V; Weisdorf DJ; Wang T; Marsh SGE; Trachtenberg E; Haagenson MD; Spellman SR; Ladner M; Guethlein LA; Parham P; Miller JS; Cooley SA
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1602-1607. PubMed ID: 27220262
[TBL] [Abstract][Full Text] [Related]
54. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
Anasetti C; Hansen JA
Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
[TBL] [Abstract][Full Text] [Related]
55. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
56. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
57. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
Miyamoto T; Fukuda T; Nakashima M; Henzan T; Kusakabe S; Kobayashi N; Sugita J; Mori T; Kurokawa M; Mori SI
Biol Blood Marrow Transplant; 2017 Jun; 23(6):938-944. PubMed ID: 28219836
[TBL] [Abstract][Full Text] [Related]
58. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Nagler A; Aker M; Or R; Naparstek E; Varadi G; Brautbar C; Slavin S
Exp Hematol; 2001 Mar; 29(3):362-70. PubMed ID: 11274765
[TBL] [Abstract][Full Text] [Related]
59. The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.
Nakata K; Takami A; Espinoza JL; Matsuo K; Morishima Y; Onizuka M; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Clin Immunol; 2013 Feb; 146(2):104-11. PubMed ID: 23291247
[TBL] [Abstract][Full Text] [Related]
60. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury.
Akamatsu Y; Haga M; Tyagi S; Yamashita K; Graça-Souza AV; Ollinger R; Czismadia E; May GA; Ifedigbo E; Otterbein LE; Bach FH; Soares MP
FASEB J; 2004 Apr; 18(6):771-2. PubMed ID: 14977880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
